ALEXIS BONSALL: Open Payments
NPI 1386084531 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$709 in 11 payments from 9 companies in 2025. Trend: 2023 $57 · 2024 $53 · 2025 $709
Food & beverage: $709
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 3 | $169 |
| Abbott Laboratories | 1 | $121 |
| Astellas Pharma US Inc | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $117 |
| Novo Nordisk Inc | 1 | $103 |
| Alkermes, Inc. | 1 | $23 |
| Alpha Cognition USA, Inc. | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: BRIXADI, FREESTYLE LIBRE 3, Veozah, Auvelity, Ozempic, VIVITROL, Zunveyl, INGREZZA.
Industry payments across LA — which companies pay providers there.
